Skip to main content

Table 2 Transplantation features

From: Allogeneic stem cell transplantation for peripheral T cell lymphomas: a retrospective study in 285 patients from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)

   

Number

Percentage

Patients

  

285

 

Disease status at transplant

Complete response

Total CR

178

62

CR1

93

 

CR ≥ 2

85

 

Partial response

Total PR

76

27

PR1

45

 

PR ≥ 2

31

 

Progressive disease

 

31

11

Time from diagnosis to transplant

 

< 12 months

149

52

Conditioning regimen

RIC

 

174

62

MAC

Total MAC

107

38

TBI-based MAC

67

Missing data

 

4

 

Graft source

PBSC

 

203

71

Bone marrow

 

49

17

CB

 

33

12

Sex of donor/recipient

F/M

 

74

27

CMV serostatus

Neg/neg

 

92

32

HLA matching

Sibling identical

 

128

45

Matched unrelated donor (10/10)

 

104

36

Mismatched unrelated donor

 

13

5

Cord blood

 

33

12

Haploidentical

 

7

2

T depletion

In vivo T depletion (ATG)

 

142

50

Ex vivo T depletion

 

4

1

  1. CR complete remission, PR partial remission, RIC reduced-intensity conditioning regimen, MAC myeloablative conditioning regimen, PBSC peripheral blood stem cells, CB cord blood, F female, M male, neg negative, ATG globulin anti-thymocytes